Clinical Trial Update: Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. [Phase 1, Phase 2]

View source ↗

Summary

Pfizer is testing PF-08634404 as a single-agent and combination therapy for unresectable or advanced hepatocellular carcinoma in a Phase 1/2 trial that is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PF-08634404

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Hepatocellular, Hepatocellular Cancer | Phase 1, Phase 2 | Status: RECRUITING